TXNRD1 and breast carcinoma: The Kaplan‐Meier survival analysis using 3021 available breast cancer patients from the Kaplan‐Meier Plotter showed that high expression of TrxR1 was significantly associated with poor prognosis of breast cancer patients (Figure 5B).